ECS Botanics Holdings Ltd - Asset Resilience Ratio
ECS Botanics Holdings Ltd (ECS) has an Asset Resilience Ratio of 5.07% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ECS liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1989–2024)
This chart shows how ECS Botanics Holdings Ltd's Asset Resilience Ratio has changed over time. See ECS Botanics Holdings Ltd shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down ECS Botanics Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ECS company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$1.67 Million | 5.07% |
| Total Liquid Assets | AU$1.67 Million | 5.07% |
Asset Resilience Insights
- Limited Liquidity: ECS Botanics Holdings Ltd maintains only 5.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ECS Botanics Holdings Ltd Industry Peers by Asset Resilience Ratio
Compare ECS Botanics Holdings Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
Drug Manufacturers - Specialty & Generic | 43.05% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277 |
Drug Manufacturers - Specialty & Generic | 31.63% |
|
Hainan Shuangcheng Pharmaceut
SHE:002693 |
Drug Manufacturers - Specialty & Generic | 3.29% |
Annual Asset Resilience Ratio for ECS Botanics Holdings Ltd (1989–2024)
The table below shows the annual Asset Resilience Ratio data for ECS Botanics Holdings Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 5.07% | AU$1.67 Million ≈ $1.18 Million |
AU$32.88 Million ≈ $23.27 Million |
+1.00pp |
| 2023-06-30 | 4.06% | AU$1.06 Million ≈ $751.34K |
AU$26.13 Million ≈ $18.49 Million |
-8.23pp |
| 2022-06-30 | 12.29% | AU$2.93 Million ≈ $2.07 Million |
AU$23.82 Million ≈ $16.86 Million |
-8.93pp |
| 2021-06-30 | 21.22% | AU$4.24 Million ≈ $3.00 Million |
AU$20.01 Million ≈ $14.16 Million |
-13.61pp |
| 2020-06-30 | 34.83% | AU$1.90 Million ≈ $1.35 Million |
AU$5.47 Million ≈ $3.87 Million |
+10.62pp |
| 2019-06-30 | 24.21% | AU$1.72 Million ≈ $1.22 Million |
AU$7.12 Million ≈ $5.03 Million |
-46.03pp |
| 2001-06-30 | 70.24% | AU$8.52 Million ≈ $6.03 Million |
AU$12.13 Million ≈ $8.58 Million |
+69.95pp |
| 2000-06-30 | 0.29% | AU$50.00K ≈ $35.38K |
AU$17.33 Million ≈ $12.26 Million |
-2.41pp |
| 1996-06-30 | 2.70% | AU$235.65K ≈ $166.74K |
AU$8.73 Million ≈ $6.18 Million |
-11.84pp |
| 1995-06-30 | 14.54% | AU$465.00K ≈ $329.02K |
AU$3.20 Million ≈ $2.26 Million |
+4.02pp |
| 1994-06-30 | 10.52% | AU$620.00K ≈ $438.69K |
AU$5.89 Million ≈ $4.17 Million |
+3.53pp |
| 1993-06-30 | 7.00% | AU$311.00K ≈ $220.05K |
AU$4.45 Million ≈ $3.15 Million |
-5.11pp |
| 1992-06-30 | 12.10% | AU$542.00K ≈ $383.50K |
AU$4.48 Million ≈ $3.17 Million |
+8.75pp |
| 1991-06-30 | 3.35% | AU$140.00K ≈ $99.06K |
AU$4.18 Million ≈ $2.96 Million |
+0.47pp |
| 1990-06-30 | 2.88% | AU$100.00K ≈ $70.76K |
AU$3.47 Million ≈ $2.45 Million |
-7.59pp |
| 1989-06-30 | 10.47% | AU$420.00K ≈ $297.18K |
AU$4.01 Million ≈ $2.84 Million |
-- |
About ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.